Abluminus DES+
Sirolimus Coated Coronary Stent
ABLUMINUS DES+ was developed from proprietary ENVISOLUTION technology to address unmet clinical needs in patients with diabetes mellitus and acute myocardial infarction with coronary artery disease.
Envisolution Technology
Abluminal Coting facilitates directional drug release and less systemic exposure of drug leading to faster re-endothelialisation
Fusion Coating - Coating on the stent and exposed parts of the balloon facilitate homogenous drug delivery which address diffused proliferative disease and focal restenosis
Edge Coating - The extra 0,5mm coating on the edge of the balloon which addresses the edge restenosis
Biodegradable Film - The formation of Sirolimus circular film with biodegradable polymer facilitates maximum drug delivery
